Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 482-330-9 | CAS number: 144020-22-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 is >5000 mg/kg bw in an OECD TG 401
Acute inhalation toxicity: LC50 is >26000 mg/m3 which is derived from the acute oral LD50 using route to route extrapolation.
Acute dermal toxicity: LD50 is >2000 mg/kg bw in an OECD TG 402
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The selected study is the key (and only) study and is adequate to cover this endpoint
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The selected study is the key (and only) study and is adequate to cover this endpoint
Additional information
Acute oral toxicity
The acute oral toxicity in female and male rats was studied in accordance to a guideline similar to OECD TG 401 and GLP principles. The substance was administered orally to one group of ten rats (5 females and 5 males) at 5000 mg/kg. Signs observed included diarrhea, lacrimation, body drop, catatonia, hunched back, gnawing at forepaws, ataxia, hypersensitivity to touch, head tremors, exophthalmus, abnormal gait, piloerection, red exudate around oral cavity, and a yellow discoloration of the fur (ventral and genital area). None of the ten rats died at 5000 mg/kg. Necropsy did not show any abnormality. The acute oral toxicity (LD50) was determined to be >5000 mg/kg.
Acute inhalation toxicity
No study on the test substance is available. In the present case, inhalation exposure will be less than dermal exposure because the substance has a low vapour pressure and dermal exposure is the more likely route of exposure. Using route to route extrapolation the inhalation toxicity can be derived as follows: an oral LD50 of >5000 mg/kg bw can be roughly converted into > 26000 mg/m3 (ECHA's CLP guidance, section, 3.1.3.3.5, 2017, using the formula: 1 mg/kg bw = 0.0052 mg/L/4h). In the present case 50/100% oral and inhalation absorption is used. The maximum saturated vapour pressure for the substance is 6,1 mg/m3 (0.06 Pa x 246 MW (mg/mol)) / (8.3 (R, gas constant) x 293 (°K)). This means that the substance cannot reach a concentration higher than 6.1 mg/m3 at 20°C. Therefore, an LC50 for inhalation cannot be reached
Acute dermal toxicity
Acute dermal toxicity in female and male rats was studied in accordance to OECD TG 402 and GLP. A group of ten rats (five males and five females) received a single topical application of the test substance, administered as supplied, at a dosage of 2000 mg/kg bodyweight for a duration of 24 hours. All animals were killed as scheduled and examined macroscopically on Day 15, the end of the observation period. There were no deaths or clinical signs following the dose level of 2000/mg/kg bodyweight. All animals gained weight throughout the study and no macroscopic findings were evident at the macroscopic examination at termination on Day 15. Very slight erythema was observed in one male and one female. The female exhibiting erythema also showed eschar/scabbing. Desquamation/exfoliation was observed in a further three animals. The acute dermal toxicity (LD50) was determined to be >2000 mg/kg.
Justification for classification or non-classification
Based on the results available, the substance does not have to be classified for acute oral, inhalation or dermal toxicity according to EU CLP (EC No. 1272/2008 and its amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
